Sweetch Company
Sweetch is an Artificial Intelligence based platform for large scale prediction, prevention and outcome improvement of chronic diseases - diabetes, hypertension, hyperlipidemia, and obesity. They believe that every individual should live a healthier lifestyle. Currently, no scalable and cost-effective solution exists that helps the prediabetic population, therefore providing some sort of guidance is vital. Sweetch reduces the risk of diabetes and improves outcomes of chronic diseases by implementing a personalized intervention that focuses on emotional support and motivation to drive behavior change. Sweetch developed a proprietary machine-learning platform that predicts an individual’s 3-year risk for developing Metabolic Syndrome related diseases – type 2 diabetes, hypertension, hyperlipidemia, and obesity.
.jpg)
(Reupload).png)
(Reupload).png)
.png)
Technology:
Machine Learning
Industry:
Healthcare
Headquarters:
Jerusalem, Yerushalayim, Israel
Founded Date:
2013
Employees Number:
1-10
Funding Status:
Early Stage Venture
Investors Number:
16
Total Funding:
$32M
Estimated Revenue:
Less than $1M
Last Funding Date:
19.07.2021
Last Funding Type:
Series A
Register and Claim Ownership